Chronic intestinal pseudo-obstruction

Current Treatment Options in Gastroenterology

Volumn 8, Issue 1, 2005, Pages 3-11

  Panganamamula, Kashyap V ^a   Parkman, Henry P ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CHOLINERGIC RECEPTOR BLOCKING AGENT; CIPROFLOXACIN; CISAPRIDE; CYANOCOBALAMIN; DOMPERIDONE; DOXYCYCLINE; ERYTHROMYCIN; FOLIC ACID; HALOPERIDOL; INSULIN; IRON; KETOCONAZOLE; METOCLOPRAMIDE; METRONIDAZOLE; MULTIVITAMIN; NEOSTIGMINE; OCTREOTIDE; PHENOTHIAZINE; PROKINETIC AGENT; SULFONYLUREA; TEGASEROD;

ABDOMINAL CRAMP; ABDOMINAL PAIN; AMENORRHEA; BACTERIAL INFECTION; CHOLESTATIC HEPATITIS; CHRONIC DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; DECOMPRESSION SURGERY; DIAGNOSTIC ACCURACY; DIARRHEA; DIETARY FIBER; DIETARY INTAKE; DIFFERENTIAL DIAGNOSIS; DRUG MECHANISM; DRUG PENETRATION; DRUG POTENTIATION; DRUG RESPONSE; ENTERIC FEEDING; EXTRAPYRAMIDAL SYMPTOM; GALACTORRHEA; GALLSTONE; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TRACT SCINTISCANNING; GASTROSTOMY; GYNECOMASTIA; HEART ARRHYTHMIA; HUMAN; HYPERGLYCEMIA; HYPERPROLACTINEMIA; HYPOGLYCEMIA; IDIOPATHIC DISEASE; IMPOTENCE; INFECTION; INSULIN HYPOGLYCEMIA; INTESTINE OBSTRUCTION; INTESTINE PSEUDOOBSTRUCTION; INTESTINE RADIOGRAPHY; INTESTINE TRANSPLANTATION; JEJUNOSTOMY; LONG TERM CARE; LOW FAT DIET; MALABSORPTION; MALNUTRITION; MANOMETRY; MYOCARDIAL DISEASE; NAUSEA; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT; PARENTERAL NUTRITION; PATIENT SELECTION; QT PROLONGATION; REVIEW; SCLERODERMA; SEDATION; SEPSIS; SINUS BRADYCARDIA; SMALL INTESTINE DISEASE; SOMNOLENCE; SYMPTOMATOLOGY; TARDIVE DYSKINESIA; TORSADE DES POINTES; TREATMENT PLANNING; UPPER GASTROINTESTINAL TRACT; VOMITING; WEIGHT REDUCTION;

EID: 13944273445     PISSN: 10928472     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11938-005-0046-4     Document Type: Review

References (37)

1. Rudolph CD, Hyman PE, Altshuler SM, et al.: Diagnosis and treatment of chronic intestinal pseudo-obstruction in children: Report of consensus workshop. J Pediatr Gastroenterol Nutr 1997, 24:102-112.
2. Stanghellini V, Camilleri M, Malagelada JR: Chronic idiopathic intestinal pseudo-obstruction: clinical and intestinal manometric findings. Gut 1987, 28:5-12.
3. Coulie B, Camilleri M: Intestinal pseudo-obstruction. Annu Rev Med 1999, 50:37-55.
4. Camilleri M, Phillips SF: Acute and chronic intestinal pseudo-obstruction. Adv Intern Med 1991, 36:287-306.
5. Smith SD, Williams CS, Ferris CD: Diagnosis and treatment of chronic Gastroparesis and chronic intestinal pseudo-obstruction. Gastroenterol Clin North Am 2003, 32:619-658.
6. Christensen J, Dent J, Malagelada JR, Wingate DL: Pseudo-obstruction. Gastroenterol Int 1990, 3:107-119.
7. Besnard M, Faure C, Fromont-Hankard G, et al.: Intestinal pseudo-obstruction and acute pandysautonomia associated with Epstein-Barr infection. Am J Gastroenterol 2000, 95: 80-284.
8. Debinski H, Kamm M, Talbot I, et al.: DNA viruses in the pathogenesis of sporadic chronic intestinal pseudo-obstruction. Gut 1997, 41:100-106.
9. Sodhi N; Camilleri M; Camoriano JK, et al.: Autonomic function and motility in intestinal pseudoobstruction caused by paraneoplastic syndrome. Dig Dis Sci 1989, 34:1937-1942.
10. Mann SD, Debinski HS, Kamm MA: Clinical characteristics of chronic idiopathic intestinal pseudo-obstruction in adults. Gut 1997, 41:675-681.
11. Jain D, Moussa K, Tandon M, et al.: Role of interstitial cells of cajal in motility disorders of the bowel. Am J Gastroenterol 2003, 98:618-624.
12. Di Lorenzo C: Pseudo-obstruction: current approaches. Gastroenterology 1999, 116:980-987.
13. Schuffler MD: Chronic intestinal pseudo-obstruction. In Sleisenger and Fordtran's Gastrointestinal and Liver disease. Edited by Feldman M. Philadelphia: WB Saunders 2002:2140-2150.
14. Parkman HP, Harris AD, Krevsky B, et al.: Gastroduodenal motility and dysmotility: An update on techniques available for evaluation. Am J Gastroenterology 1995, 90: 69-892.
15. Bonapace ES, Davidoff S, Krevsky B, et al.: Whole gut transit scintigraphy in the clinical evaluation of patients with upper and lower gastrointestinal symptoms. Am J Gastroenterol 2000, 95:2838-2847.
16. Scolapio JS, Ukleja A, Bouras EP, et al.: Nutritional management of chronic intestinal pseudo-obstruction. J Clin Gastroenterol 1999, 28:306-312.
17. Patrick PG, Marulendra S, Kirby DF, et al.: Endoscopic nasogastric-jejunal feeding tube placement in critically ill patients. Gastrointest Endosc 1997, 45:72-76.
18. Warner E, Jeejeebhoy KN: Successful management of chronic intestinal pseudo-obstruction with home parenteral nutrition. JPEN 1985, 9:173-78.
19. Cheng S, Philip C, Berquist WE, et al.: Home central venous hyperalimentation in fifteen patients with severe scleroderma bowel disease. Arthritis Rheum 1989, 32:312-16.
20. Feighner SD, Tan CP, McKee KK, et al.: Receptor for motilin identified in the human gastrointestinal system. Science 1999, 284:2184-88.
21. Quigley EM: Chronic intestinal pseudo-obstruction. Curr Reat Options Gastroenterol 1999, 2:239-250.
22. Emmanuel AV, Shand AG, Kamm MA: Erythromycin for the treatment of chronic intestinal pseudo-obstruction: description of six cases with a positive response. Aliment Pharmacol Ther 2004, 15:687-694.
23. Camilleri M, Malajelada JR, Abell TL, et al.: Effect of six weeks of treatment with cisapride in gastroparesis and intestinal pseudoobstruction. Gastroenterology 1989, 96:704-712.
24. Camilleri M, Balm RK, Zinmeister AR: Determinants of response to a prokinetic agent in neuropathic chronic intestinal motility disorder. Gastroenterology 1994, 106:916-923.
25. Camilleri M, Balm RK, Zinmeister AR: Symptomatic improvement with one-year cisapride treatment in neuropathic chronic intestinal motility. Aliment Pharmacol Ther 1996, 10: 03-409.
26. Prather CM, Camilleri M, Zinsmeister AR, et al.: Tegaserod accelerates orocecal transit in patients with constipation predominant irritable bowel syndrome. Gastroenterology 2000, 118:463-68.
27. Soudah HC, Hasler WL, Owyang C: Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma. N Engl J Med 1991, 325:1461-1467.
28. Verne JN, Eaker EY, Hardy E, et al.: Effect of octreotide and erythromycin on idiopathic and scleroderma associated intestinal pseudo obstruction. Dig Dis Sci 1995, 40: 892-1901.
29. Ponec RJ, Saunders MD, Kimmey MB: Neostigmine for the treatment of acute colonic pseudo-obstruction. N Engl J Med 1999, 341:137-141.
30. Thompson AR, Pearson T, Ellul J, Simpson JN: Percutaneous endoscopic colostomy in patients with chronic intestinal pseudo-obstruction. Gastrointest Endosc 2004, 59:113-115.
31. Murr MM, Sarr MG, Camilleri M: The surgeon's role in the treatment of chronic intestinal pseudoobstruction. Am J Gastroenterol 1995, 90:2147-2151.
32. Shibata C, Naito H, Funayama Y, et al.: Surgical treatment of chronic intestinal pseudo-obstruction: report of three cases. Surg Today 2003, 33:58-61.
33. Grant D: Current results of intestinal transplantation: the International Intestinal Transplant Registry. Lancet 1996, 347:1801-1803.
34. Niv Y, Mor E, Tzakis A: Small bowel transplantation-a clinical review. Am J Gastroenterol 1999, 94:3126-3130.
35. Langnas AN: Advances in small intestine transplantation. Transplantation 2004, 77:S75-S78.
36. Anuras S, Camilleri M: Dysmotility of the small intestine. In: Textbook of Gastroenterology. Edited by Yamada T. Philadelphia: WB Saunders; 1999:1584-1610.
37. Snape WJ Jr.: Disorders of gastrointestinal motility. In Cecil Text Book of Medicine. Edited by Bennett G. Philadelphia: Lippincott Williams & Wilkins; 2000:694-702.